S4 Medical lands $5M to take atrial fibrillation device to market


S4 Medical Corp. has raised $5 million to take its medical device through regulatory approvals and into production.

Previous CytoDyn hits up former business partner for $100M in damages
Next Case targeting CVS billing practices involving BCBS continues in federal court